FDA Drug recall D-0202-2025
glipiZIDE, Extended-Release Tablets, 2.5 mg, 30-count (3x10 blister cards) carton, Rx Only, Distributed by: American Health Packaging, Colu…
- FDA Drug
- Class II
- terminated
- Published 2025-01-22
On 2025-01-22 the FDA classified a Class II recall of glipiZIDE, Extended-Release Tablets, 2.5 mg, 30-count (3x10 blister cards) carton, Rx Only, Distributed by: American Health Packaging, Colu… by Amerisource Health Services, citing failed Dissolution Specifications:.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0202-2025 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2024-12-17 |
| Published | 2025-01-22 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Amerisource Health Services |
| Distribution | US |
Product
glipiZIDE, Extended-Release Tablets, 2.5 mg, 30-count (3x10 blister cards) carton, Rx Only, Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC: 60687-480-21, Unit Dose NDC: 60687-480-11
Reason
Failed Dissolution Specifications:
Identifiers
| code_info | Lot # 1012910, Exp Date: 04/30/2025 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0202-2025%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.